Department of Medicine, Division of Cardiovascular Medicine, Division of Cardiology, University of Toledo, 3000 Arlington Ave, Toledo, OH 43614, USA.
Department of Medicine, Beth Israel Lahey Health, Burlington, MA, USA.
Curr Probl Cardiol. 2024 Feb;49(2):102233. doi: 10.1016/j.cpcardiol.2023.102233. Epub 2023 Dec 3.
Inflammation of the myocardium, or myocarditis, presents with varied severity, from mild to life-threatening such as cardiogenic shock or ventricular tachycardia storm. Existing data on sex-related differences in its presentation and outcomes are scarce. Using the Nationwide Readmission Database (2016-2019), we identified myocarditis hospitalizations and stratified them according to sex to either males or females. Multivariable regression analyses were used to determine the association between sex and myocarditis outcomes. The primary outcome was in-hospital mortality, and the secondary outcomes included sudden cardiac death (SCD), cardiogenic shock (CS), use of mechanical circulatory support (MCS), and 90-day readmissions. We found a total of 12,997 myocarditis hospitalizations, among which 4,884 (37.6 %) were females. Compared to males, females were older (51 ± 15.6 years vs. 41.9 ± 14.8 in males) and more likely to have connective tissue disease, obesity, and a history of coronary artery disease. No differences were noted between the two groups with regards to in-hospital mortality (adjusted odds ratio [aOR] 1.20; confidence interval [CI] 0.93-1.53; P = 0.16), SCD (aOR:1.18; CI 0.84-1.64; P = 0.34), CS (aOR: 1.01; CI 0.85-1.20;P = 0.87), or use of MCS (aOR: 1.07; CI:0.86-1.34; P = 0.56). In terms of interventional procedures, females had lower rates of coronary angiography (aOR: 0.78; CI 0.70-0.88; P < 0.01), however, similar rates of right heart catheterization (aOR 0.93; CI:0.79-1.09; P = 0.36) and myocardial biopsy (aOR: 1.16; CI:0.83-1.62; P = 0.38) compared to males. Additionally, females had a higher risk of 90-day all-cause readmission (aOR: 1.25; CI: 1.16-1.56; P < 0.01) and myocarditis readmission (aOR:1.58; CI 1.02-2.44; P = 0.04). Specific predictors of readmission included essential hypertension, congestive heart failure, malignancy, and peripheral vascular disease. In conclusion, females admitted with myocarditis tend to have similar in-hospital outcomes with males; however, they are at higher risk of readmission within 90 days from hospitalization. Further studies are needed to identify those at higher risk of readmission.
心肌炎症,即心肌炎,其严重程度不一,从轻到危及生命不等,如心源性休克或室性心动过速风暴。目前关于其临床表现和结局的性别差异的相关数据十分有限。本研究使用全国再入院数据库(2016-2019 年),确定了心肌炎住院患者,并根据性别分为男性或女性。采用多变量回归分析确定性别与心肌炎结局之间的关系。主要结局为院内死亡率,次要结局包括心源性猝死(SCD)、心源性休克(CS)、使用机械循环支持(MCS)和 90 天再入院率。我们共发现 12997 例心肌炎住院患者,其中 4884 例(37.6%)为女性。与男性相比,女性年龄更大(51±15.6 岁 vs. 41.9±14.8 岁),且更易患有结缔组织疾病、肥胖和冠心病。两组间院内死亡率(调整后比值比[aOR]1.20;95%置信区间[CI]0.93-1.53;P=0.16)、SCD(aOR:1.18;CI 0.84-1.64;P=0.34)、CS(aOR:1.01;CI 0.85-1.20;P=0.87)或 MCS 使用(aOR:1.07;CI:0.86-1.34;P=0.56)均无差异。在介入治疗方面,女性接受冠状动脉造影的比例较低(aOR:0.78;CI 0.70-0.88;P<0.01),但右心导管检查(aOR 0.93;CI:0.79-1.09;P=0.36)和心肌活检(aOR:1.16;CI:0.83-1.62;P=0.38)的比例与男性相似。此外,女性 90 天全因再入院(aOR:1.25;CI:1.16-1.56;P<0.01)和心肌炎再入院(aOR:1.58;CI 1.02-2.44;P=0.04)的风险更高。再入院的具体预测因素包括原发性高血压、充血性心力衰竭、恶性肿瘤和外周血管疾病。总之,患有心肌炎的女性住院期间的结局与男性相似,但她们在出院后 90 天内再入院的风险更高。需要进一步研究以确定哪些患者再入院风险更高。